Rpob gene mutation profile in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Guizhou, One of the highest incidence rate regions in China

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 6, 2010, Pages 1299-1301

  Chen, Ling ^a   Gan, Xin ^a   Li, Nana ^a   Wang, Jianhua ^a   Li, Kailun ^a   Zhang, Hong ^a,b  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b Z BioMed Inc   (United States)

Author keywords

M. tuberculosis; Rifampicin resistance; TB

Indexed keywords

RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CHINA; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; GENE MUTATION; GENE SEQUENCE; GEOGRAPHIC DISTRIBUTION; INCIDENCE; LETTER; MISSENSE MUTATION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENE FREQUENCY; HUMANS; INCIDENCE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; RIFAMPIN; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS;

EID: 77953569636     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq102     Document Type: Letter

References (20)

1. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273:220-6.
2. WHO. WHO Report 2008. Global Tuberculosis Control: Surveillance, Planning, Financing. http://www.searo.who.int/LinkFiles/Reports_fullreport_2008.393 .pdf (15 October 2009, date last accessed).
3. Zignol M, Hosseini MS, Wright A et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-85.
4. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995; 8: 496-514.
5. WHO. The Global Plan to Stop TB 2006-2015. http://www.who.int/tb/features_archive/global_plan_to_stop_tb/en/index.h tml (15 October 2009, date last accessed).
6. Caoili JC, Mayorova A, Sikes D et al. Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 2378-81.
7. Guo JH, Xiang WL, Zhao QR et al. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Sichuan Province in China. Jpn J Infect Dis 2008; 61: 264-8.
8. Jiao WW, Mokrousov I, Sun GZ et al. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin Med J 2007; 120: 814-9.
9. Fan XY, Hu ZY, Xu FH et al. Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in Shanghai by using the amplification refractory mutation system. J Clin Microbiol 2003; 41: 993-7.
10. Ma X, Wang H, Deng Y et al. rpoB gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol 2006; 44: 3409-12.
11. Sheng J, Li J, Sheng G et al. Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China. J Appl Microbiol 2008; 105: 904-11.
12. Chan RC, Hui M, Chan EW et al. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2007; 59: 866-73.
13. Caws M, Duy PM, Tho DQ et al. Mutations prevalent among rifampinand isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J Clin Microbiol 2006; 44: 2333-7.
14. Lee AS, Lim IH, Tang LL et al. High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore. J Clin Microbiol 2005; 43: 2026-7.
15. Mani C, Selvakumar N, Narayanan S et al. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 2001; 39: 2987-90.
16. Doustdar F, Khosravi AD, Farnia P et al. Mutations in rpoB gene and genotypes of rifampin resistant Mycobacterium tuberculosis isolates in Iran. Tanaffos 2008; 7:11-7.
17. Chaves F, Alonso-Sanz M, Rebollo MJ et al. rpoB mutations as an epidemiologic marker in rifampin-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2000; 4: 765-70.
18. Valim AR, Rossetti ML, Ribeiro MO et al. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil. J Clin Microbiol 2000; 38: 3119-22.
19. Cavusoglu C, Hilmioglu S, Guneri S et al. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 2002; 40: 4435-8.
20. Mikhailovich V, Lapa S, Gryadunov D et al. Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol 2001; 39: 2531-40.